Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|February 9, 2016
Do medical oncologists and cancer patients care about treatment costs of systemic anticancer therapy?Erdinc Nayir, Alper Ata, Ali AricanJournal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 30, 2016
Ganoderma Lucidum (Reishi Mushroom) and cancerAhmet Unlu, Erdinc Nayir, Onder Kirca, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|January 1, 2017
Ginseng and cancerAhmet Unlu, Erdinc Nayir, Onder Kirca, et al.Asian Pacific Journal of Cancer Prevention : APJCP|November 28, 2017
Oncologists’ Perspectives on Consolidation Radiation Treatment after Chemotherapy for Lymphomas: A Survey Study by the Lymphoma Working Committee of the Turkish Oncology Group (TOG)Ozgur Tanriverdi, Ibrahim Barista, Semra Paydas, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 13, 2016
Curcumin (Turmeric) and cancerAhmet Unlu, Erdinc Nayir, Muhammed Dogukan Kalenderoglu, et al.Clinical Laboratory|February 10, 2022
Prognostic Importance of Inflammatory Indexes in Patients Treated by Pazopanib for Soft Tissue SarcomaTolga Koseci, Veysel Haksoyler, Polat Olgun, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|May 26, 2019
Addition of taxanes to combination chemotherapy in distal intestinal gastric cancer is more beneficial than proximal ones: A multicenter retrospective study of Turkish Oncology GroupAli Murat Sedef, Fatih Kose Ahmet Taner Sumbul, Ali Ayberk Besen, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|August 30, 2016
Tendency of cancer patients and their relatives to use internet for health-related searches: Turkish Oncology Group (TOG) StudyErdinc Nayir, Ozgur Tanriverdi, Yusuf Karakas, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 3, 2017
Attitudes of cancer patients after diagnosis: How cancer affects social life? A Turkish Oncology Group studyErdinc Nayir, Mahmut Bakir Koyuncu, Ece Esin, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 4, 2019
A retrospective analysis on first-line bevacizumab, cetuximab, and panitimumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG)Serkan Degirmencioglu, Ozgur Tanriverdi, Serkan Menekse, et al.Pageof 2